93939 - CDKN2A Sequencing and Deletion/Duplication
Mutations in CDKN2A are associated with Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. Individuals with a CDKN2A have an increased risk for melanoma (28-76% risk to age 80) and pancreatic cancer. This test detects pathogenic variants in the CDKN2A gene.